Key details
Sponsor
Brigham and Women's Hospital
Collaborators
Portola Pharmaceuticals
Enrollment target
~400 participants
Primary completion
December 2022
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years and older
Last updated February 2026